411 / 1498
“No Role” for Radiotherapy- The Primary Study
739 Patients III-IV HD
MOPP-ABV x 6-8 (2 cycles after CR)
57% CR 34% PR
333 (45%) CR randomized: 227 (31%) PR
24 Gy IFRT or no RT 30 Gy RT
EORTC H34
(Aleman et al.)
NEJM 248:24, 2003